Chicago Virus

A woman in Chicago in her sixties was Friday confirmed as the second patient on US soil infected with a deadly new virus originating in China, health officials said, with 50 other suspected cases under investigation.

According to a study conducted by the University of Chicago and the University of Pittsburgh School of Medicine, infection with reovirus, a common but harmless virus, may trigger the immune system response to gluten that leads to celiac disease.

Scientists across the United States say they cannot obtain samples of Ebola, complicating efforts to understand how the virus is mutating and develop new drugs, vaccines and diagnostics.

Scientists leading the fight against Middle East Respiratory Syndrome say the next critical front will be understanding how the virus behaves in people with milder infections, who may be spreading the illness without being aware they have it.

A daily dose of powerful anti-HIV medicine helped cut the risk of infection with the AIDS virus by 49 percent in intravenous drug users in a Bangkok study that showed for the first time such a preventive step can work in this high-risk population.

A woman in Chicago in her sixties was Friday confirmed as the second patient on US soil infected with a deadly new virus originating in China, health officials said, with 50 other suspected cases under investigation.

According to a study conducted by the University of Chicago and the University of Pittsburgh School of Medicine, infection with reovirus, a common but harmless virus, may trigger the immune system response to gluten that leads to celiac disease.

Scientists across the United States say they cannot obtain samples of Ebola, complicating efforts to understand how the virus is mutating and develop new drugs, vaccines and diagnostics.

Scientists leading the fight against Middle East Respiratory Syndrome say the next critical front will be understanding how the virus behaves in people with milder infections, who may be spreading the illness without being aware they have it.

A daily dose of powerful anti-HIV medicine helped cut the risk of infection with the AIDS virus by 49 percent in intravenous drug users in a Bangkok study that showed for the first time such a preventive step can work in this high-risk population.